KIORA PHARMACEUTICALS INC - Common Stock, $0.01 par value (KPRX)

Historical Holders from Q2 2024 to Q2 2025

Symbol
KPRX on Nasdaq
CUSIP
49721T507
Type / Class
Equity / Common Stock, $0.01 par value
Shares outstanding
3.58M
All holders as of June 30, 2025
Q2 2025
Total 13F shares, excl. options
932K
Holdings value
$2.68M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
16
Number of buys
5
Number of sells
-8
Average Value change %
0%
Average buys %
0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of KIORA PHARMACEUTICALS INC - Common Stock, $0.01 par value (KPRX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ADAR1 Capital Management, LLC 9.9% $1.03M 365K ADAR1 Capital Management GP, LLC Jun 30, 2025
Nantahala Capital Management, LLC 9.99% $799K 306K Nantahala Capital Management, LLC Sep 30, 2024
HIRSCHMAN ORIN 8.5% $667K 256K Orin Hirschman Dec 31, 2024
Nantahala Capital Partners Limited Partnership 5.3% $535K 190K NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP Aug 8, 2025
Alyeska Investment Group, L.P. 2.5% $197K 75.6K Alyeska Investment Group, L.P. Dec 31, 2024
GOLDMAN SACHS GROUP INC 0% $339 130 THE GOLDMAN SACHS GROUP, INC. Dec 31, 2024

Institutional Holders of KIORA PHARMACEUTICALS INC - Common Stock, $0.01 par value (KPRX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q2 932K $2.68M -$1.05M $2.88 16
2025 Q1 1.29M $3.87M +$78.1K $3.01 18
2024 Q4 1.26M $4.16M +$76.9K $3.30 16
2024 Q3 1.21M $4.44M +$906K $3.66 18
2024 Q2 966K $4.06M +$4.06M $4.20 15